E126 (Letrozole 2.5 mg)
Pill with imprint E126 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Qualitest Pharmaceuticals.
Letrozole is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for E126
Letrozole
- Imprint
- E126
- Strength
- 2.5 mg
- Color
- Yellow
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Qualitest Pharmaceuticals
- National Drug Code (NDC)
- 00603-4180 (Discontinued)
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
polyvinyl alcohol,
corn starch,
magnesium silicate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "E126"
More about letrozole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (319)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: aromatase inhibitors
Patient resources
- Other brands
- Femara
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.